Variables | Complete sample | Control group | HELP group | P-value |
---|---|---|---|---|
Gender(n) % | 0.608 | |||
Male | (112) 55.9% | (62)55.9% | (50) 59.5 | |
Marital Status | 0.276 | |||
Married | (129) 66.15% | 68(61.26%) | (61)72.62% | |
Widowed | (63) 32.31% | 40(36.4%) | (23)27.38% | |
Other | (3) 1.53% | 3(0.27%) | 0 | |
Education | 0.176 | |||
Illiterate | (122)62.56% | (74)66.67% | (48)57.14% | |
Primary School | (65)33.33% | (35)31.53% | (30)35.71% | |
High School | (2)2.38% | 0 | (2)1.03% | |
University | (6)3.08% | (2)1.8% | (4)4.76% | |
Polypharmacy | 0.647 | |||
Less than three drugs | (52)26.67% | (31)27.93% | (21)25% | |
More than three drugs | (143)73.33% | (80)72.07% | (63)65% | |
AddictionYes | (14)7.18% | (10)9.01% | (4)4.76% | 0.255 |
Charlson Comorbidity Index; mean ± SD | 2.72 ± 1.83 | 2.66 ± 1.82 | 2.79 ± 1.85 | 0.624 |
Hypertension | (118)60.51% | (67)60.36% | (51)60.76% | 1.000 |
Diabetes | (79)40.51% | (38)34.23% | (41)48.81% | 0.055 |
aCAD | (103)52.82% | (57)51.35 | (46)54.76 | 0.834 |
CHFb | (27)13.85% | (18)16.22% | (9)10.71% | 0.271 |
cCVA | (14)7.18% | (8)7.21% | (6)7.14% | 1.000 |
Parkinson | (4)2.055 | (3)2.70% | (1)1.19% | 0.636 |
History of dementia | (18)9.23% | (12)10.81% | (6)7.145 | 0.381 |
Kidney failure | (31)15.90% | (18)16.22% | (13)15.48% | 0.889 |
Liver failure | (7)3.59% | (5)4.50% | (2)2.38% | 0.701 |
COPD | (28)10.81% | (12)10.81% | 16)19.05%) | 0.148 |
Depression | (15)7.69% | (7)6.31% | (8)9.53% | 0.461 |
Cancer | (8)4.10% | (5)4.50% | (3)3.57% | 1.000 |
Frailty Index | 0.191 | |||
Very fit | (1)0.5% | 0 | (1)1.2% | |
Well – without active disease | (14)7.2% | (7)6.3% | (7)8.3% | |
Well, with treated comorbid disease | (31)15.9% | (20)18% | (11)13.1% | |
Apparently vulnerable | (52)26.7% | (30)27% | (22)26.2% | |
Mildly frail | (24)12.3% | (9)8.1% | (15)17.9% | |
Moderately frail, | (53)27.2% | (30)27% | (23) 27.4% | |
Severely frail | (20)10.3% | (15)13.5% | (5)6% | |
Age; mean ± SD (years) | 5.87 ± 78.53 | 6.01 ± 77.75 | 5.72 ± 79.12 | 0.108 |
SPMSQ score mean ± SD | 3.30 ± 2.96 | 3.50 ± 3.12 | 2.73 ± 3.05 | 0.288 |
score Digit span mean ± SD | 4.76 ± 2.28 | 4.20 ± 2.85 | 5.19 ± 2.81 | 0.229 |
ADL-Barthel mean ± SD | 16.46 ± 5.37 | 16.18 ± 5.29 | 16.83 ± 5.48 | 0.015 |
Targeted risk factors | ||||
Cognition impairment | (102)52.2% | (59)53.2% | (43)51.2% | 0.217 |
Immobility | (114)58.46% | (66)59.41% | (48)57.14 | 0.255 |
Visual impairment | (126)64.26% | (73)65.77% | (53)63.10% | 0.534 |
Hearing impairment | (78)40% | (48)43.24% | (30)35.71% | 0.334 |
Dehydration | (79)40.5% | (41)36.9% | (38)45.2% | 0.242 |
Sleep disorder | (88)45.13% | (47)42.34% | (41)48.81% | 0.273 |